<DOC>
	<DOC>NCT00448916</DOC>
	<brief_summary>The study will evaluate the long-term safety and tolerability of pregabalin in pediatric patients, age 1 month through 16 years, with partial onset seizures.</brief_summary>
	<brief_title>Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Partial onset seizures, incompletely controlled on 13 medications At least 1 seizure per 28 days, on average Completion of study A0081074 Primary generalized seizures Progressive CNS pathology Failure to tolerate pregabalin in study A0081074</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability</keyword>
</DOC>